Figure 4From: Taurolidine reduces the tumor stimulating cytokine interleukin-1beta in patients with resectable gastrointestinal cancer: a multicentre prospective randomized trialSurvival A)Overall local recurrence free rate b) Overall metastases free rate.Back to article page